These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9636630)

  • 41. Ganciclovir prophylaxis of cytomegalovirus disease.
    Conti DJ; Shen G; Singh T; Isenberg A; Freed BM
    Transplant Proc; 1997; 29(1-2):804-6. PubMed ID: 9123534
    [No Abstract]   [Full Text] [Related]  

  • 42. Experience with azathioprine withdrawal after simultaneous kidney-pancreas transplantation.
    Stratta RJ
    Transplant Proc; 1998 Jun; 30(4):1353-4. PubMed ID: 9636550
    [No Abstract]   [Full Text] [Related]  

  • 43. The incidence of interstitial and vascular kidney rejection after pancreas-kidney transplantation.
    Boonstra JG; Bruijn JA; Hermans J; Lemkes HH; Ringers J; van der Pijl H; van der Woude FJ
    J Am Soc Nephrol; 1995 May; 5(11):1918-25. PubMed ID: 7620088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term results of OKT3-treated renal transplant recipients.
    Tanabe K; Takahashi K; Sonda K; Tokumoto T; Koga S; Nakazawa H; Goya N; Yagisawa T; Fuchinoue S; Kawai T; Toma H; Ota K
    Transplant Proc; 1996 Jun; 28(3):1350-1. PubMed ID: 8658689
    [No Abstract]   [Full Text] [Related]  

  • 45. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.
    Woodle ES; Xu D; Zivin RA; Auger J; Charette J; O'Laughlin R; Peace D; Jollife LK; Haverty T; Bluestone JA; Thistlethwaite JR
    Transplantation; 1999 Sep; 68(5):608-16. PubMed ID: 10507477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients.
    Piatosa B; Grenda R; Prokurat S
    Transplant Proc; 1993 Aug; 25(4):2574. PubMed ID: 8356675
    [No Abstract]   [Full Text] [Related]  

  • 47. OKT3-induced cytokine-release syndrome: occurrence beyond the second dose and association with rejection severity.
    Vasquez EM; Fabrega AJ; Pollak R
    Transplant Proc; 1995 Feb; 27(1):873-4. PubMed ID: 7879215
    [No Abstract]   [Full Text] [Related]  

  • 48. OKT3 induction in 100 consecutive pancreas transplants.
    Stratta RJ; Taylor RJ; Lowell JA; Bynon JS; Cattral MS; Frisbie K; Miller S; Brennan DC
    Transplant Proc; 1994 Apr; 26(2):546-7. PubMed ID: 8171546
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract]   [Full Text] [Related]  

  • 50. Thymoglobulin induction decreases rejection in solitary pancreas transplantation.
    Stegall MD; Kim DY; Prieto M; Cohen AJ; Griffin MD; Schwab TR; Nyberg SL; Velosa JA; Gloor JM; Innocenti F; Bohorquez H; Dean PG; Carpenter HA; Leontovich ON; Sterioff S; Larson TS
    Transplantation; 2001 Nov; 72(10):1671-5. PubMed ID: 11726830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two low-dose OKT3 induction regimens following renal transplantation--clinical experience at a single center.
    Oh HK; Provenzano R; Tayeb J; Satmary N; Jones B
    Clin Transplant; 1998 Aug; 12(4):343-7. PubMed ID: 9686329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantation.
    Norman DJ; Kimball JA; Bennett WM; Shihab F; Batiuk TD; Meyer MM; Barry JM
    Transpl Int; 1994 Aug; 7(5):356-61. PubMed ID: 7993573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Economic evaluation of immunosuppressive drugs: an empirical example using a secondary database of hospital charges.
    Schommer JC; Pathak DS; Grauer DW
    Transplant Proc; 1996 Apr; 28(2):906. PubMed ID: 8623455
    [No Abstract]   [Full Text] [Related]  

  • 54. Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation.
    Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
    Transplant Proc; 1998 Jun; 30(4):1170-2. PubMed ID: 9636473
    [No Abstract]   [Full Text] [Related]  

  • 55. Prolonged neurological disability following OKT3 therapy for acute renal transplant rejection.
    Jeffrey RF; Johnson MH; Bamford JM; Giles GR; Brownjohn AM; Will EJ
    Transplantation; 1993 Mar; 55(3):677-9. PubMed ID: 8456493
    [No Abstract]   [Full Text] [Related]  

  • 56. OKT3 induction therapy and cadaveric renal transplantation in black patients.
    Reinitz ER; Kaplan MP; Sillix DH; Lysz K
    Transplant Proc; 1997 Dec; 29(8):3703-5. PubMed ID: 9414892
    [No Abstract]   [Full Text] [Related]  

  • 57. Risk-benefit of OKT3 prophylaxis in immunologic high-risk cadaver kidney transplant recipients.
    Cogny-Van Weydevelt F; Prud'Homme L; Boucher A; Dandavino R
    Transplant Proc; 1997 Nov; 29(7A):32S-34S. PubMed ID: 9366926
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term results of pancreas transplantation under tacrolius immunosuppression.
    Jordan ML; Shapiro R; Gritsch HA; Egidi F; Khanna A; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ
    Transplantation; 1999 Jan; 67(2):266-72. PubMed ID: 10075592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience.
    Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO
    Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449
    [No Abstract]   [Full Text] [Related]  

  • 60. The National Transplantation Pregnancy Registry: comparison between pregnancy outcomes in diabetic cyclosporine -treated female kidney recipients and CyA-treated female pancreas-kidney recipients.
    Armenti VT; McGrory CH; Cater J; Radomski JS; Jarrell BE; Moritz MJ
    Transplant Proc; 1997; 29(1-2):669-70. PubMed ID: 9123472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.